
Hualan
301207.SZHualan Biological Bacterin Inc. Price (301207.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
602,429,841
(0.4025)%Description
Hualan Biological Bacterin Inc. engages in the research, development, production, and sale of vaccines in China. It offers It offers influenza virus split vaccines, quadrivalent influenza virus split vaccines, H1N1 influenza virus split vaccines, ACYW135 meningococcal polysaccharide plague vaccines, recombinant hepatitis B vaccines, and group A and C meningococcal polysaccharide vaccines, as well as genetic engineering vaccines for human use. The company was founded in 2005 and is based in Xinxiang, China. Hualan Biological Bacterin Inc. was formerly a s... Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $15.42-25.29
- Market Cap 10.71B
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Biotechnology
- ceo: Ms. Wenjue An
- IPO Date: February, 18, 2022
- Country: CN
- Currency: CNY
- Headquaters: No Data
- Employees: 770
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
